UOC
CSII

UBS O'Connor’s Cardiovascular Systems, Inc. CSII Stock Holding History

UBS O'Connor’s Portfolio CSII Stock Details CSII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-61,040
Closed -$831K – 788
2022
Q4 		$831K Buy
61,040
+15,637
+34% +$218K 0.02% 582
2022
Q3 		$629K Sell
45,403
-5,000
-10% -$74.3K 0.01% 791
2022
Q2 		$724K Sell
50,403
-9,597
-16% -$167K 0.01% 790
2022
Q1 		$1.36M Buy
+60,000
New +$1.16M 0.01% 650

Other funds holding CSII

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
WIC
Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

UBS O'Connor's CSII Position: Q1 2023 in Review

UBS O'Connor sold out of Cardiovascular Systems, Inc. (CSII) in Q1 2023, closing a stake of 61,040 shares — an estimated $831K sold.

UBS O'Connor first reported a position in CSII in Q1 2022 and held it in 4 quarters. The position peaked at $1.36M in Q1 2022. 150 funds tracked by Wall St. Rank hold CSII as of Q1 2023.

  • UBS O'Connor reported no remaining Cardiovascular Systems, Inc. position as of Q1 2023 after selling out during the quarter.
  • UBS O'Connor sold 61,040 Cardiovascular Systems, Inc. shares in Q1 2023, an estimated $831K.
  • UBS O'Connor first reported a position in Cardiovascular Systems, Inc. in Q1 2022 and held it in 4 quarters.
  • UBS O'Connor's Cardiovascular Systems, Inc. position peaked at $1.36M in Q1 2022.
  • 150 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q1 2023.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.